Biotech RadarJobs updated

COMPANY

Applied Biologics

appliedbiologics.com ↗

Clinical Phase 3

Profile checked Oct 10, 2026

Keywords: Diabetic Foot Ulcer Diabetic Foot Foot Ulcer Ulcer Foot Pressure Ulcer Amniotic Membrane Placental Allograft Biologic Foot Ulcer Due to Type 2 Diabetes Mellitus Foot Ulcer Due to Type 1 Diabetes Mellitus Pressure Wound Pressure Area Diabetic Foot Ulcers Foot Ulcer Chronic Ulcer Knee Osteoarthritis Rotator Cuff Tear Fatty Atrophy mHACMb

7Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Di source ↗
  2. Trial start —: Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial. source ↗
  3. Trial start Phase 4: A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ul source ↗
  4. Trial start Phase 4: A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers source ↗
  5. Trial start Not phased (device or behavioral study): Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care source ↗
  6. Trial start Phase 2: Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee source ↗
  7. Trial start Not phased (device or behavioral study): Efficacy of an Amniotic Fluid Derived Allograft, (FlōGraft®) in Rotator Cuff Repairs: A Prospective Study source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 7

RecordTitlePhaseStatusStartPrimary completion
NCT07852338a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot UlcersPhase 3RecruitingOct 8, 20262028-11 (estimated)
NCT07159282A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot UlcersPhase 4RecruitingAug 26, 20252027-08 (estimated)
NCT07126886A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure UlcersPhase 4RecruitingJun 11, 20252027-08 (estimated)
NCT07360418Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.Not listedRecruitingOct 16, 20252027-10 (estimated)
NCT06564831Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of CareNot phased (device or behavioral study)RecruitingSep 20, 20242025-02 (estimated)
NCT03441607Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the KneePhase 2Unknown status (ClinicalTrials.gov)2018-112019-02 (estimated)
NCT03379324Efficacy of an Amniotic Fluid Derived Allograft, (FlōGraft®) in Rotator Cuff Repairs: A Prospective StudyNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Mar 24, 2017Sep 30, 2019 (estimated)
Feedback